Cargando…
Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer
Triple-negative breast cancer (TNBC) displays an aggressive clinical course, heightened metastatic potential, and is linked to poor survival rates. Through its lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), this subt...
Autores principales: | Dees, Sundee, Pontiggia, Laura, Jasmin, Jean-Francois, Mercier, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515519/ https://www.ncbi.nlm.nih.gov/pubmed/32164483 http://dx.doi.org/10.1080/15384047.2020.1726718 |
Ejemplares similares
-
Development of CAPER peptides for the treatment of triple negative breast cancer
por: Chilewski, Shannon D., et al.
Publicado: (2020) -
Essential role of STAT5a in DCIS formation and invasion following estrogen treatment
por: Dees, Sundee, et al.
Publicado: (2020) -
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
por: Jia, Zan-Hui, et al.
Publicado: (2017) -
Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3(Tyr705) phosphorylation
por: Sun, Xiaodong, et al.
Publicado: (2020) -
STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT–MET switch and cancer metastasis
por: Lin, Wei-Hsin, et al.
Publicado: (2020)